ClinicalTrials.govpublic full text
A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
pain, advanced cancer, cancer pain, opioid therapy, inadequate analgesia, optimized chronic opioid therapy, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 979581
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.